Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
Open Access
- 5 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 269 (2), 583-586
- https://doi.org/10.1007/s00415-021-10731-2
Abstract
SARS-CoV-2 infection is associated with an increased rate of thromboembolic events and mortality. Different vaccines are globally used to limit the pandemic. In this report, we present the case of two young female patients with newly diagnosed cerebral sinus vein thrombosis occurring after injection of the vector-based ChAdOx1 vaccine. Both patients presented with unusual headache only. The two of them used an estrogen-containing contraception, had had a history of deep venous thrombosis, and both had MTHFR mutations. Both patients developed SARS-CoV-2 specific humoral and cellular immunity including both CD4 and CD8 T cells. This rare, but serious complication needs to be considered after vaccination of young females, even if there is no evidence of heparin-induced thrombocytopenia.Funding Information
- Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
This publication has 12 references indexed in Scilit:
- COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in GermanyAnnals of Neurology, 2021
- Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicJAMA, 2021
- Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)Journal of Thrombosis and Haemostasis, 2021
- COVID‐19 patients often show high‐titer non‐platelet‐activating anti‐PF4/heparin IgG antibodiesJournal of Thrombosis and Haemostasis, 2021
- MTHFR Gene Polymorphisms and Cardiovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus ThrombosisBrain Sciences, 2020
- High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19JCI Insight, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Thrombosis of the Cerebral Veins and SinusesThe New England Journal of Medicine, 2005